Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |21 October 2003

Delayed Drug Hypersensitivity Free

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
  • The summary below is from the full report titled Delayed Drug Hypersensitivity Reactions. It is in the 21 October 2003 issue of Annals of Internal Medicine (volume 139, pages 683-693). The author is W.J. Pichler.


Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.
×
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • What is the problem and what is known about it so far?
    • Why did the author do this review?
    • How did the author do this review?
    • What did the author find?
    • What are the implications of this review?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

What is the problem and what is known about it so far?

Allergic drug reactions (hypersensitivity) are unpredictable. Many drug hypersensitivity reactions produce severe skin rashes. Drug-induced skin hypersensitivity reactions can occur rapidly after exposure (immediate-type hypersensitivity) or after a delay of a few days (delayed hypersensitivity). Delayed hypersensitivity is due to interactions between the drug and a particular type of white blood cell known as a T cell. Although T cells help the body develop immunity against infection, they can also cause adverse effects in certain circumstances. T cells produce harmful effects in allergic drug reactions through a series of complex biological reactions. Recent discoveries have broadened our understanding of how T cells produce drug hypersensitivity in the skin.

Why did the author do this review?

To educate physicians about newer theories on how allergic drug reactions are produced.

How did the author do this review?

The author reviewed recent publications that investigated the biological interactions that occur between drugs and T cells.

What did the author find?

T cells possess specialized chemical receptors on their outer surfaces, giving them the ability to recognize foreign substances. For a drug to react with a receptor, it must first be presented to the surface of the T cell by another cell in a way that holds the reactive portion of its structure in the correct position for interaction to take place. This often requires that the drug hook a ride on a larger chemical that clamps it into the correct position by forming a chemical bond with the drug. If the drug is not chemically reactive enough to produce a chemical bond, it can sometimes be modified by the body's metabolism into a form that can then effectively bond with the larger chemical. Recently, researchers have recognized a third way that a drug can react with T cells, even if it cannot form a chemical bond with the carrier chemical. This involves a much looser connection (known as a labile connection) with the T cell or the carrier. A labile connection is based on the structure of the drug rather than its chemical reactivity. In this method of reaction, the drug tucks into the receptor structure without forming a chemical bond but is still able to stimulate the immune receptor. The manner of drug presentation (chemical bond vs. labile connection) may determine what kinds of hypersensitivity reaction can occur in the skin. Drug hypersensitivity reactions may kill cells in various layers of the skin, forming blisters or severe destruction; alternatively, they may be characterized by inflammation. The actual form of the skin reaction depends on the specific chemicals released by the T cell in response to the offending drug.

What are the implications of this review?

Drug allergies are complicated reactions that involve many different chemical and biological interactions. Recognition of novel mechanisms may provide better methods of preventing and treating these diseases.

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Delayed Drug Hypersensitivity. Ann Intern Med. 2003;139:I–46. doi: https://doi.org/10.7326/0003-4819-139-8-200310210-00005

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2019

×
Permissions

Published: Ann Intern Med. 2003;139(8):I-46.

DOI: 10.7326/0003-4819-139-8-200310210-00005

©
2003 American College of Physicians
0 Citations

See Also

Delayed Drug Hypersensitivity Reactions
View MoreView Less

Related Articles

Drug Provocation Tests in Patients with a History Suggesting an Immediate Drug Hypersensitivity Reaction
Annals of Internal Medicine; 140 (12): 1001-1006
Tests To Confirm Drug Allergy in Patients with a History of Possible Immediate Allergic Reactions to Drugs
Annals of Internal Medicine; 140 (12): I-30
Delayed Drug Hypersensitivity Reactions
Annals of Internal Medicine; 139 (8): 683-693
Diagnostic Tests for Patients with Suspected Allergic Disease: Utility and Limitations
Annals of Internal Medicine; 110 (4): 304-312
View MoreView Less

PubMed Articles

Genetic susceptibility to angiotensin-converting enzyme-inhibitor induced angioedema: A systematic review and evaluation of methodological approaches.
PLoS One 2019;14(11):e0224858.
Safety profile of HTX-019 administered as an intravenous push in cancer patients: a retrospective review.
Expert Opin Drug Saf 2019.
View More

Results provided by: PubMed

CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×